Brightseed Launches Enterprise AI Solution to Streamline Formulation and Manufacturing Success
· Source: pharmaceuticalcommerce.com
In short
Brightseed has launched a clinically validated enterprise AI platform designed to integrate discovery, development, and commercialization phases into a unified architecture. The platform addresses high failure rates in pharmaceutical and wellness industries by connecting fragmented workflows and data sets, with its Forager AI discovery engine optimizing formulation and manufacturing decisions. This represents a shift from a discovery-focused bioactives firm to a platform-based enterprise AI company serving the global wellness market.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 13, 2026: AI-Driven Execution and Security Shift Supply Chain Into High-ROI Operating Systems
Tags: pharmaceutical, manufacturing, formulation, AI, supply-chain, optimization